If they don't have money for a buyback, they don't have money for a dividend. The CEO messaging has been clear they need to retain funds until they definitively know trial costs so not sure why this keeps getting brought up as an option??
Doing a buyback or a divvy now (to satisfy people focused on something CEO has no control over and should imo, not try and manage) and then being forced to partner for our 2nd Ph3 trial (or raise capital) feels like it would be a very bad idea.
If they don't have money for a buyback, they don't have money...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.35 |
Change
0.520(3.76%) |
Mkt cap ! $1.834B | |||
| Open | High | Low | Value | Volume |
| $13.96 | $14.35 | $13.66 | $6.469M | 457.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2023 | $14.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.38 | 1777 | 1 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |